LIVZON PHARMACEUTICAL GROUP INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.98 CNY | -1.32% |
|
+2.99% | +11.34% |
ETFs positioned on Livzon Pharmaceutical Group Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.42% | 4 M€ | -2.96% | ||
| 0.36% | 2 M€ | -16.59% | - | |
| 0.05% | 35 M€ | -5.85% | - | |
| 0.02% | 3 M€ | -0.84% | - | |
| 0.02% | 4 M€ | -11.56% | ||
| 0.00% | 2,808 M€ | +5.90% | - | |
| 0.00% | 441 M€ | +4.60% | - | |
| 0.00% | 149 M€ | +2.17% | - | |
| 0.00% | 31 M€ | +3.50% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 15 M€ | +11.24% |
LIVZON PHARMACEUTICAL GROUP INC. is a China based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products include western medicine preparation such as gastrointestinal drugs, cardiovascular drugs and antimicrobial drugs and gonadotrophin drugs, Chinese medicine preparation, active pharmaceutical ingredient and intermediates, diagnostic reagents and equipments. The Company distributes its products in the domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-20
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
38.98
CNY
Average target price
40.8
CNY
Spread / Average Target
+4.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.34% | 4.34B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 000513 Stock
- Funds and ETFs Livzon Pharmaceutical Group Inc.
